Sentences with phrase «general psychiatric symptoms»

There were no significant differences between patients in both placebo and fluoxetine groups on measures of general psychiatric symptoms, global functioning or self - reported depressive symptom measurements (Moldenhauer & Melnyk, 1999).

Effect sizes were calculated for target problems, general psychiatric symptoms, and social functioning using the data published in the original studies.

Results Short - term psychodynamic psychotherapy yielded significant and large pretreatment - posttreatment effect sizes for target problems (1.39), general psychiatric symptoms (0.90), and social functioning (0.80).

Short - term psychodynamic psychotherapy yielded significant and large pretreatment - posttreatment effect sizes for target problems (1.39), general psychiatric symptoms (0.90), and social functioning (0.80).

This was also true for CBT (target problems, 1.37 vs 1.33; general psychiatric symptoms, 1.01 vs 0.97; social functioning, 0.97 vs 1.05).

For STPP, the pre — follow - up effectsizes were stable (target problems, 1.44 vs 1.57; general psychiatric symptoms, 0.91 vs 0.95; social functioning, 0.89 vs 1.19).

Contrary to the meta - analyses of Crits - Christoph5 andAnderson and Lambert, 7 studies of IPT werenot included (eg, Elkin et al30 and Wilfleyet al31), because the relation of IPT to STPPis controversial, and empirical results suggest that IPT is very close toCBT.9 Thus, this review includes only studiesfor which there is a general agreement that they represent models of STPP.As it is questionable to aggregate the results of very different outcome measuresthat refer to different areas of psychological functioning, we assessed theefficacy of STPP separately for target symptoms, general psychiatric symptoms (ie, comorbid symptoms), and social functioning.32 Thisprocedure is analogous to the meta - analysis of Crits - Christoph.5 Asoutcome measures of target problems, we included patient ratings of targetproblems and measures referring to the symptoms that are specific to the patientgroup under study, eg, measures of anxiety for studies investigating treatmentsof anxiety disorders.33 For the efficacy ofSTPP in general psychiatric symptoms, broad measures of psychiatric symptomssuch as the Symptom Checklist - 90 and specific measures that do not refer specificallyto the disorder under study were included; eg, the Beck Depression Inventoryapplied in patients with personality disorders.34, 35 Forthe assessment of social functioning, the Social Adjustment Scale and similarmeasures were included.36

We assessed outcomes in target problems, general psychiatric symptoms, and social functioning.

Not exact matches

«Three beliefs about God were tested separately in ordinary least squares regression models to predict five classes of psychiatric symptoms: general anxiety, social anxiety, paranoia, obsession, and compulsion,» reads the abstract for this paper.

Researchers at Massachusetts General Hospital and Harvard Medical School have developed a new method to extract valuable symptom information from doctors» notes, allowing them to capture the complexity of psychiatric disorders that is missed by traditional sources of clinical data.

The SS cohort reported significantly better outcomes over one year in employment, social support, general symptoms of psychiatric distress, and symptoms of PTSD, particularly avoidance and arousal clusters.

This questionnaire was developed in a hospital outpatient clinic, avoiding questions that could be influenced by physical illness symptoms72 and has since been found a reliable measure of anxiety and depression symptom severity in physical and psychiatric illness, primary care patients and general population.73 It has been validated for Portuguese patients.74

Compared to non-LD peers, youth with LD frequently report feelings of loneliness, stress, depression and suicide, among other psychiatric symptoms.15, 16 For example, in the National Longitudinal Study of Adolescent Health, the LD sample was twice as likely to report a suicide attempt in the past year.16 Longitudinal research on risk - taking indicates that, compared to non-LD peers, adolescents with LD engage more frequently in various risk behaviours.17 Therefore, the presence of LD in childhood appears to confer a general risk for adverse outcomes throughout adolescence and into adulthood.

Several psychotherapy treatments specifically developed for patients with borderline personality disorder (BPD) have proven to be effective.1 General psychiatric management (GPM) is one of the therapies that have been shown to be effective for reducing recurrent suicidal and self - harm behaviour, symptom distress and borderline personality disorder features.2 However, these proven effective therapies1, 2 have generally been delivered over 1 — 3 years of therapy.

Such analyses are an important part of psychiatric epidemiology, which in contrast with general epidemiology, deals with changing content of diagnoses and continuing refinement of taxonomic constructs.23 One important finding from these studies on TRAILS data was that only few adolescents had exclusively DSM - IV anxiety or exclusively DSM - IV depressive symptoms (DSM - IV = Diagnostic and Statistical Manual of mental disorders, 4th edition).

This trial demonstrated that 1 year of dialectical behavior therapy or general psychiatric management for the treatment of suicidal patients with borderline personality disorder brought about significant reductions in suicidal behavior, borderline symptoms, general distress from symptoms, depression, anger, and health care utilization, along with improvements in interpersonal functioning.

Physical symptoms in outpatients with psychiatric disorders consulting the general internal medicine division at a Japanese university hospital

The global prevalence of depression and depressive symptoms has been increasing in recent decades.1 The lifetime prevalence of depression ranges from 20 % to 25 % in women and 7 % to 12 % in men.2 Depression is a significant determinant of quality of life and survival, accounting for approximately 50 % of psychiatric consultations and 12 % of all hospital admissions.3 Notably, the prevalence of depression or depressive symptoms is higher in patients than in the general public.3 — 6 The underlying reasons include the illness itself and the heavy medical cost, unsatisfactory medical care service and poor doctor — patient relationship.7 8 Several informative systematic reviews on specific groups of outpatients have been published.